EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics | MicrobiomeTrials← Back to trialsNCT05979545
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2023-12-12Est. Completion: 2027-10-31
Enrollment target: 1,526 participants Locations- Christian Medical College Vellore, Vellore, India
- Hospital Pulau Pinang, George Town, Malaysia
- Hospital Raja Permaisuri Bainun, Ipoh, Malaysia
- University Malaya Medical Centre, Kuala Lumpur, Malaysia
- Sarawak General Hospital, Kuching, Malaysia
- Hospital Seberang Jaya, Seberang Jaya, Malaysia
- National University Hospital, Singapore, Singapore
- Tan Tock Seng Hospital, Singapore, Singapore
- Korea University Ansan Hospital, Ansan, South Korea
- Soonchunhyang University Cheonan Hospital, Cheonan, South Korea
- Kyungpook National University Chilgok Hospital, Daegu, South Korea
- Seoul National University Bundang Hospital, Seongnam, South Korea
- Taichung Veterans General Hospital, Taichung, Xitun District, Taiwan
- Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan
- Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan
- National Taiwan University Hospital, Taipei, Taiwan
- Siriraj Hospital, Bangkok, Thailand
Other microbiome trials you might be interested in
Dialysis
This study is a prospective, single arm, multi-center two-stage feasibility study designed to evaluate the safety and ef…
Hartford, United StatesEst. completion Dec 30, 2026
Blood Stream InfectionsAdult Cancer Patients
Sepsis and bloodstream infection (BSI) are among the most serious complications in patients with cancer, in whom disease…
Sohag, EgyptEst. completion Oct 2027
Songklanagarind Hospital, Hat Yai, ThailandSrinagarind Hospital, Khon Kaen University, Khon Kaen, ThailandSunpasitthiprasong Hospital, Ubon Ratchathani, ThailandMedipol Mega University Hospital, Istanbul, Turkey (Türkiye)